Alibaba Health Information Technology Limited (ALBBY)

Market Cap	6.33B -32.4%
Revenue (ttm)	4.97B +12.0%
Net Income	280.71M +35.2%
EPS	0.02 +34.6%
Shares Out	n/a
PE Ratio	22.54
Forward PE	18.90
Dividend	n/a
Ex-Dividend Date	n/a

Volume	433
Open	7.98
Previous Close	7.99
Day's Range	7.83 - 7.98
52-Week Range	7.83 - 19.45
Beta	1.60
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About ALBBY

Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. The company offers a range of prescription and over-the-counter drugs, nutritional supplements, medical devices, contact lenses, healthcare food, adult and family planning products, and various other health-related products. It also provides medical and healthcare services, including medical checkups, medical c...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 1998
• Employees: 1,429
• Stock Exchange: OTCMKTS
• Ticker Symbol: ALBBY

Financial Performance

In fiscal year 2026, ALBBY's revenue was 34.26 billion, an increase of 11.95% compared to the previous year's 30.60 billion. Earnings were 1.94 billion, an increase of 35.17%.

Financial numbers in CNY

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 26, 2026

Data Sources Report a data error